NTA hit a record NZ$1.26 but the portfolio trailed its benchmark by 2.7pp

Against that modest active result, NTA per share reached an unprecedented NZ$1.26 versus the supplied historical range of NZ$0.80-NZ$1.02, and net assets attributable closed at NZ$242.1m versus a four-period mean of NZ$200.4m.

Headline profit figures fell against the post-pandemic HY21 comparable: investment total return of NZ$6.3m (HY21 NZ$32.3m, -80.6%) and NPAT of NZ$3.6m (-86.0%). The supplied historical baseline classifies the current investment total return as within normal range — HY21 was the outlier, not HY22 the collapse.

The operating cash inflow of NZ$5.3m reversed a NZ$19.6m outflow in HY21, while cash on hand fell to NZ$4.5m from NZ$7.4m.

For an actively managed listed investment company this is the cleanest period scorecard, and it shows manager selection added less than passive exposure during the half. The benchmark's 4.2% itself sits below its historical mean of 9.1%, so both absolute and relative reads are subdued.

The distribution materially exceeded earnings. The 132.4% payout ratio versus NPAT sits well above the historical mean of 52.8% (range 38.1%-65.3%), reflecting 5.06 cents paid during the period against thin period earnings. Investment-company distributions can be funded from realised gains and capital reserves, but the gap raises a question about how sustained the current distribution rate is if portfolio returns stay modest.

Balance-sheet scale is strong. NTA per share of NZ$1.26 is an unprecedented high and net assets attributable of NZ$242.1m are above their historical range. The tension is that the NAV level was built largely in prior periods of market strength; current-half active performance did not add to it.

HY21 was a record period for the issuer, and Annolyse's historical baseline shows it was the outlier on both investment income and NPAT margin. That comparable is plainly non-repeatable, so the headline year-on-year drop is not a deterioration signal.

What this release does support is that NTA per share and net assets are at record levels. What it does not support is any conclusion on whether active portfolio management will close the 2.7pp benchmark gap in the second half. The implied second-half NPAT of NZ$43.3m in FY21 was driven by exceptional market conditions, so an analogous H2 lift should not be assumed mechanically.

The current investment total return of NZ$6.3m and portfolio return of 1.5% both sit within the supplied historical ranges. For this issuer, the quality reading turns on relative performance, NAV durability, and distribution funding.

On those terms the quality reading is mixed. The 2.7pp underperformance versus benchmark is the durability concern — it is the reading on active management, not on market direction, and it stands against a benchmark that itself returned below its historical mean. The unprecedented NTA per share of NZ$1.26 is a genuinely strong balance-sheet outcome but reflects accumulated prior-period gains rather than this half's activity. The distribution policy at 132.4% of NPAT cannot be funded from current earnings alone and is drawing on capital reserves; that is acceptable for an investment company in principle, but it requires strong cumulative returns over time.

The effective tax rate of 13.8% sits above the historical baseline mean of 5.2% and at the top of the historical range. No commentary in the release explained the step-up.

This briefing cannot assess multi-year performance attribution, fee-structure mechanics, or the forward portfolio positioning that will drive the second half.